Illumina expands access to genomics in Latin America

By The Science Advisory Board staff writers

April 20, 2022 -- Illumina has launched a new state-of-the-art facility in São Paulo, Brazil, that will expand global access to genomics in Latin America. The 11,000-sq-ft site features a fully operational lab equipped with Illumina technology to help train customers and partners throughout Brazil and Latin America.

The new Solution Center will enable Illumina to offer its partners an environment for demonstrations and training sessions to optimize their education and experience with next-generation sequencing and array technologies focusing on basic research and clinical applications.

Illumina also partnered with the Ministry of Health in Brazil to build a comprehensive public health network for tracking the spread of the virus. About 26 laboratories out of 28 in the country use Illumina's sequencing systems.

Illumina Solution Center. Image courtesy of Illumina.
Illumina Accelerator invests in 7 genomics startups
Illumina has invested in seven new genomics companies to join the fourth global funding cycle of Illumina Accelerator San Francisco Bay Area and Cambridge,...
Tataa Biocenter, Olink, Illumina partner on high-throughput proteomics
Tataa Biocenter has launched Olink EXPLORE 3072, a high-throughput proteome profiling service, made possible using Illumina's sequencing technology.
Illumina collaborates with National Cancer Center Japan
Illumina and National Cancer Center Japan are collaborating on an international joint research project that will use Illumina's high-throughput DNA sequencing...
Illumina delivers results, growth plans at JP Morgan Healthcare Conference
Illumina's CEO, Francis deSouza, discussed the company's growth trajectory, including 2021 results and 2022 guidance at the 2022 virtual J.P Morgan Healthcare...
Gretel, Illumina partner to develop synthetic data for genomic research
Gretel announced a collaboration with Illumina to create synthetic genomic data that can be accessed by medical researchers globally. The companies also...

Copyright © 2022

Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter